DRAP Approves Massive Price Hike For 253 Medicines

The Drug Regulatory Authority (DRAP) has notified a 22 to 35 percent increase in the prices of 253 medicines. This is the second upward revision in medicine prices in less than a month.

The DRAP notification did not include the names of the medicines.

President Pakistan Drug Lawyers Forum (PDLF), Noor Mohammad Mahar, claimed that notification was originally issued on October 5 but was made public earlier this week.


ALSO READ

Pakistani Students Win Big at the Annual Silk Road and Young Dreams Awards


PDLF President rejected the government’s decision and urged it to retract the notification.

Earlier on September 24, the federal government had approved the price hike for 94 life-saving drugs to ‘ensure their availability in the market.’

Commenting on the development, Special Assistant to Prime Minister (SAPM) on Health, Dr. Faisal Sultan, had said that the recent hike was ‘inevitable’ to ensure their uninterrupted supply of the medicines.


ALSO READ

FBR Discovers Rs. 12.8 Billion in a Dry Cleaner’s Bank Account


He supported the DRAP’s decision and called it a ‘reasonable increase.’ Dr. Sultan said that pharmaceutical companies stop producing essential medicines if prices are not increasing, which creates a shortage across the country.

He said that the increase in prices was approved to avoid a shortage of life-saving drugs.


  • nawaz sharif aur zardari mil k sazish ker rhay hain hamaray imran khan k khilaf, apni bimari k bahanay sari medicines market say khareed leen to medicine short ho gai. ab govt ko majboori mein mahngi kerni par rhi hain. Ye nawaz sharif aur zardari is hakoomat ko khatam kerna chahtay hain aur awam ko imran khan k khilaf kerna chahtay hain.

  • Dude. incorrect article. These prices are not increased. These medicines were not even available in the market so how can you call it an “increase” in price. They have just fixed the price


  • Get Alerts

    Follow ProPakistani to get latest news and updates.


    ProPakistani Community

    Join the groups below to get latest news and updates.



    >